IP Library › Granted Patent US 8,268,961
Granted Patent B2
US 8,268,961 · App. 11/632,449 · Granted Sep 18, 2012

Antibacterial peptides and analogues thereof

Assignee: Universita Degli Studi di Siena
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,268,961
App. No.
11/632,449
Granted
Sep 18, 2012
Kind
B2
Abstract

Antibacterial peptides and their multimeric analogues, with a wide range of action and low haemolytic activity are described. In particular, the peptide molecules exhibit a high antimicrobial activity against numerous bacterial species, with reduced cytotoxicity and a low haemolysis rate. The molecules of the invention are advantageously usable as therapeutic agents and coadjutants against infections caused by strains that are resistant to common antibiotics.

Claims (13)

1. An antibacterial peptide consisting of one of the following amino acid sequences from the amino to the carboxylic terminal QAKIRVRLSA [SEQ ID NO: 2], QKKIRVRLSA [SEQ ID NO: 4] or KIRVRLSA [SEQ ID NO: 3].

2. The peptide of claim 1 being of linear form.

3. An antibacterial peptide consisting of one of the following amino acid sequences from the amino to the carboxylic terminal QAKIRVRLSA [SEQ ID NO: 2], QKKIRVRLSA [SEQ ID NO: 4] or KIRVRLSA [SEQ ID NO: 3], wherein said peptide is in linear form multimerised on a skeleton of polyacrylamide, on a skeleton of dextrane units or on a skeleton of ethylene glycol units.

4. The peptide of claim 1 , being in the form of Multiple Antigenic Peptide (MAP), having the following formula:

in which R is the peptide as claimed in claim 1 , X is a trifunctional molecule; m=0 or 1; n=0, if m=0; n=0 or 1 if m=1.

5. The MAP peptide according to claim 4 , wherein X is an amino acid having at least two functional aminic group.

6. The MAP peptide according to claim 5 , wherein X is lysine, ornithine, nor-lysine or amino alanine.

7. The MAP peptide according to claim 4 , wherein X is aspartic acid or glutamic acid.

8. The MAP peptide according to claim 4 , wherein X is propylene glycol, succinic acid, diisocyanates or diamines.

9. A pharmaceutical composition comprising a pharmaceutically acceptable and effective quantity of the peptide according to claim 1 .

10. The pharmaceutical composition according to claim 9 , in the form of eyewash, mouth wash, ointment, or solution for topical use.

11. A disinfectant and/or detergent preparation with antibacterial activity comprising the peptide according to claim 1 .

12. Food products and/or cosmetic products and/or homeopathic products comprising the peptide according to claim 1 .

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED ON REEL 026918 FRAME 0190. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S NAME SHOULD READ AS: UNIVERSITA DEGLI STUDI DI SIENA. Recorded Sep 26, 2011
From: BRACCI, LUISA; GIULIANI, ANDREA; PINI, ALESSANDRO; NERI, PAOLO
To: UNIVERSITA DEGLI STUDI DI SIENA
Reel/Frame 026973/0811 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2011
From: BRACCI, LUISA; GIULIANI, ANDREA; PINI, ALESSANDRO; NERI, PAOLO
To: UNIVERSITA DELGI STUDI DI SIENA
Reel/Frame 026918/0190 →
Priority Claims (1)
IT RM2004A0349 · Jul 13, 2004 · national
Continuity (1)
Related Publication 20090053151A1 · Feb 26, 2009